Bnp Paribas Asset Management Holding S.A. Zai Lab LTD Transaction History

Bnp Paribas Asset Management Holding S.A.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$23.14 - $49.68 $162,627 - $349,151	-7,028 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$27.77 - $64.4 $195,167 - $452,603	7,028 New	7,028 $309,000
Q1 2021 May 05, 2021	SELL	$126.27 - $191.71 $63.7 Million - $96.6 Million	-504,092 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$81.94 - $135.34 $34.4 Million - $56.9 Million	420,364 Added 502.06%	504,092 $68.2 Million
Q3 2020 Nov 09, 2020	SELL	$73.3 - $89.48 $8,136 - $9,932	-111 Reduced 0.13%	83,728 $6.96 Million
Q2 2020 Aug 04, 2020	BUY	$48.82 - $82.53 $1.98 Million - $3.35 Million	40,614 Added 93.96%	83,839 $6.89 Million
Q1 2020 May 12, 2020	BUY	$39.1 - $62.9 $1.69 Million - $2.72 Million	43,225 New	43,225 $2.23 Million

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.59B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Bnp Paribas Asset Management Holding S.A., based on Form 13F filings with the SEC.

Stay updated on Bnp Paribas Asset Management Holding S.A. with notifications on news.